Overview

Stress & Social Cognition in BPD (Part 2)

Status:
Recruiting
Trial end date:
2023-12-22
Target enrollment:
Participant gender:
Summary
The investigators will examine how a combination of pharmacological mineralocorticoid receptor (MR) stimulation and psychosocial stress will influence prosocial behavior in patients with Borderline Personality Disorder (BPD) compared to healthy controls (HC).
Phase:
N/A
Details
Lead Sponsor:
Charite University, Berlin, Germany
Treatments:
Fludrocortisone